Chitosan Based Scaffolds and Their Applications in Wound Healing  by Ahmed, Shakeel & Ikram, Saiqa
Achievements in the Life Sciences 10 (2016) 27–37
Contents lists available at ScienceDirect
Achievements in the Life Sciences
j ourna l homepage: www.e lsev ie r .com/ locate /a l sChitosan Based Scaffolds and Their Applications in Wound Healing
Shakeel Ahmed 1, Saiqa Ikram ⁎,1
Bio/Polymers Research Laboratory, Department of Chemistry, Jamia Millia Islamia (A Central University), New Delhi-110025, Indiaa r t i c l e i n f o⁎ Corresponding author.
E-mail addresses: shakeelchem11@gmail.com (S. Ah
Peer review under responsibility of Far Eastern Fed
1 Tel.: +91-11-26981717X3255.
http://dx.doi.org/10.1016/j.als.2016.04.001
2078-1520/© 2016 Far Eastern Federal Universit
(http://creativecommons.org/licenses/by-nc-nd/4.0/).a b s t r a c tArticle history:
Received 16 September 2015
Received in revised form 27 March 2016
Accepted 7 April 2016
Available online 2 June 2016Over the last decade, much interest has been developed in biopolymer based materials due to
their biocompatible, biodegradable, non-toxic and non-allergenic nature. Chitosan is a unique
biopolymer that exhibits outstanding properties, besides biocompatibility and biodegradability.
Most of these peculiar properties arise from the presence of primary amines along the chitosan
backbone. Many works have been done to obtain chitosan based scaffolds, including surface
modiﬁcations, the fabrication of chitosan based blends, chitosan based composite scaffolds,
and drug-loaded scaffolds. This study provides an overview of the key features of inherent
properties of chitosan, their modiﬁcation, and its use in biomedical engineering particularly to-
ward anti-inﬂammatory and wound healing.
© 2016 Far Eastern Federal University. Hosting by Elsevier B.V. This is an open access article
under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).Keywords:
Biopolymer
Chitosan
Biomedical engineering
Wound healingContents
Introduction . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 27
Chitosan . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 28
Modiﬁcations of Chitosan . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 28
Antimicrobial Nature of Chitosan . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 29
Anti-inﬂammatory Nature of Chitosan . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 30
Biomedical Applications of Chitosan . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 30
Wound Healings. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 30
Chitosan in Wound Healings . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 31
Chitosan with Synthetic/Natural Polymer Blend scaffolds in Wound Healings . . . . . . . . . . . . . . . . . . . . . . . . . . . . 31
Chitosan Based Composite Scaffolds in Wound Healings . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 32
Chitosan Based Sponges in Wound Healing. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 33
Chitosan Based Oil Immobilized Scaffolds in Wound Healings . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 34
Chitosan Based Extract Immobilized Scaffolds in Wound Healings . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 34
Chitosan Based Drug Loaded Scaffolds in Wound Healings . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 35
Conclusions and Future Prospective . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 35
Acknowledgements . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 35
References . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 35
8med), sikram@jmi.ac.in (S. Ikram).
eral University.
y. Hosting by Elsevier B.V. This is an open access article under the CC BY-NC-ND license
28 S. Ahmed, S. Ikram / Achievements in the Life Sciences 10 (2016) 27–37Introduction
In all biomedical applications today, polymers are playing an important role. Many notable advances in technology have
followed exploitation of the properties offered by new polymeric materials like blends and composites (Kittur et al., 2002;
Muzzarelli and Muzzarelli, 2005; Qin et al., 2012; Chee, 1990; Sun et al., 1992). Biopolymers include the polysaccharides such
as cellulose, starch, the carbohydrate polymers produced by bacteria and fungi and animal protein based biopolymers such as chi-
tin, chitosan, wool, silk, gelatin and collagen; biopolymers, especially the carbohydrate origin, have been found to have a very
promising industrial application in various forms (Singh, 2011). Most commercial polysaccharides (e.g., cellulose, dextran, pectin,
alginic acid, agar–agar, agarose, starch, carrageenan, and heparin) are either neutral or acidic, but chitosan is a basic polysaccha-
ride. In neutral or basic pH, chitosan contains free amino groups and is insoluble in water, while in acidic pH, chitosan is soluble in
water due to protonation of amino groups. The solubility depends on the distribution of free amino and N-acetyl groups (Wu and
Bough, 1978; Costa-Pinto et al., 2011). Chitosan is a linear polyelectrolyte at acidic pH. It has high charge density, one charge per
glucosamine. The pH and ionic strength have an important impact on the intrinsic viscosity of polyelectrolytes. Chitosan in aque-
ous acid solution has been surface reacted with polyanion aqueous solutions (heparin, sodium alginate, carboxymethyl chitin,
polyacrylic acid) to give polyelectrolyte complexes (Rinaudo and Domard, 1989; Dutkiewicz and Tuora, 1992).
Chitosan
Chitosan is a copolymer which consists of β-(1 → 4)-linked 2-acetamido-2-deoxy-D-glucopyranose and 2-amino-2-deoxy-D-
glucopyranose units. This is generally obtained by alkaline deacetylation of chitin, which is the main component of the exoskel-
eton of crustaceans, such as shrimps. Chitin is a naturally abundant mucopolysaccharide and is second to cellulose in terms of the
amount produced annually by biosynthesis. Chitin is a common constituent of the exoskeleton in animals, particularly in crusta-
ceans, mollusks and insects. The structure of chitosan (deacetylated chitin) is very similar to cellulose (Fig. 1); however less at-
tention has been paid to chitin than cellulose, primarily due to its inertness. Hence, it remains an essentially unutilized
resource. Deacetylation of chitin yields chitosan, which is a relatively reactive compound and is produced in numerous forms,
such as powder, paste, ﬁlm and ﬁbre. Chitosan is soluble in dilute aqueous acetic, lactic, malic, formic and succinic acids
(Skotak et al., 2011; Shakeel et al., 2014; Shakeel and Saiqa, 2015a; Mudasir et al., 2015a). Chitosan is polycationic at pH b 6
and it readily interacts with negatively charged molecules, such as proteins, anionic polysaccharides (e.g., alginate and carrageen-
an), fatty acids, bile acids and phospholipids. Nonetheless, chitosan may also selectively chelate metal ions such as iron, copper,
cadmium and magnesium (Mudasir et al., 2015b). Much attention has been paid to chitosan based biomedical materials, because
of its unique properties such as biodegradability, non-toxicity, anti-bacterial effect and biocompatibility. Chitosan is a beneﬁt to
wound healing because it stimulates haemostasis and accelerates tissue regeneration. For a material to be used for biomedical re-
search, a natural product is preferred because these materials are more biocompatible than synthetic materials. Chitosan is me-
tabolized by certain human enzymes, such as lysozyme, thus, it is biodegradable. Chitosan is an attractive material for a tissue
engineering scaffold because it has structural similarities to glycosaminoglycans and is hydrophilic. Chitosan's monomeric unit,
N-acetylglucosamine, occurs in hyaluronic acid, an extracellular macromolecule that is important in wound repair (Muzzarelli,
1996; Keong and Halim, 2009).
Modiﬁcations of Chitosan
An effective approach for developing a clinically applicable chitosan is to modify the surface of the material to provide excel-
lent biofunctionality and bulk properties. Surface modiﬁcation techniques to blend various compound derivatives include coating,
oxidation by low-temperature plasma and surfactant addition in order to blend with various derivatives. Furthermore, chitosan
can be fabricated into a stable, porous bioscaffold via surface modiﬁcation and lyophilization. However, blending with various
additives may affect its biocompatibility. Therefore, evaluation of the biocompatibility of various biomedical-grade chitosan
derivatives is necessary to engineer material that is of high quality and biocompatible for human wound management. They
offer the advantage of being easily processed into gels, membranes, nanoﬁbres, nanoﬁbrils, beads, microparticles, nanoparticles,
scaffolds and sponge-like forms (Fig. 2). Due to these properties and its biocompatibility, it has versatile applications in tissue
engineering, wound healing, as excipients for drug delivery and gene delivery (Anithaa et al., 2014).Fig. 1. Structure of (A) Chitosan and (B) Cellulose.
Fig. 2. Schematic representation of the possibilities of processing chitosan into different forms.
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eters inﬂuencing the characteristics of chitosan are its molecular weight (MW) and degree of deacetylation (DD), representing the
proportion of deacetylated units. These parameters are determined by the conditions set during preparation. Moreover, they can
be further modiﬁed. For example, the DD can be lowered by deacetylation (Zhang and Cui, 2012) and MW can be lowered by
acidic depolymerisation (Sorlier et al., 2001). In medical and pharmaceutical applications, chitosan is used as a component in
hydrogels. In crosslinked hydrogels, polymeric chains are interconnected by cross linkers, leading to the formation of a 3D net-
work. Cross linkers are molecules of MW much smaller than the MW of the chains between two consecutive crosslinks
(Knapczyk et al., 1994). The properties of crosslinked hydrogels depend mainly on their crosslinking density, namely the ratio
of moles of crosslinking agent to the moles of polymer repeating units. Moreover, a critical number of crosslinks per chain is re-
quired to allow the formation of a network. The structures of chitosan hydrogels formed are: (a) chitosan cross-linked with itself;
(b) hybrid polymer network; (c) semi-interpenetrating network; and (d) ionic crosslinking (Berger et al., 2004). Depending on
the nature of the cross linker, the main interactions forming the network are covalent or ionic bonds.Antimicrobial Nature of Chitosan
Chitosan is a potent antimicrobial agent and its antimicrobial character is due to presence of its cationic nature. An antimicro-
bial is an agent that kills microorganisms or inhibits their growth (Antimicrobial-Deﬁnition from the Merriam-Webster Online
Dictionary). Chitosan possesses unique properties that make it an ideal ingredient for development of antimicrobial edible ﬁlm.
Chitosan is an antimicrobial non-toxic biopolymer that has been proven to serve as a matrix to obtain edible ﬁlms. The interaction
(binding or chelation) of chitosan with endotoxins of Gram-negative bacteria decreased their acute toxicity. Because of the strong
chelating ability of chitosan, external chelating agents such as EDTA may not be required, when antimicrobial agents such as nisin
are added to chitosan to control Gram negative bacteria. Chitosan's ability to inhibit a wide variety of bacteria, fungi, yeasts, and
viruses make its application in a broad range or variety of antimicrobial agents in experiments involving in vivo and in vitro in-
teractions in different forms (solutions, ﬁlms and composites). Chitosan-dependent antimicrobial activity has been observed
against various microorganisms, such as fungi, algae and bacteria (Shakeel et al., 2015). These antimicrobial effects are controlled
by intrinsic factors, including the type of chitosan, the degree of chitosan polymerization, the host, the natural nutrient constitu-
ency, the chemical or nutrient composition of the substrates and the environmental conditions (e.g., substrate water activity or
moisture or both). The photo-cross-linked electrospun mats containing quartinized chitosan (QCS) were efﬁcient in inhibiting
growth of Gram-positive bacteria and Gram-negative bacteria and the results suggested that the cross-linked QCS/PVP electrospun
mats were found to be promising materials for wound-dressing (Jayakumar et al., 2010). The antimicrobial activities of chitosan
differs mainly in live host plants e.g. the fungicidal effects of N-carboxymethyl chitosan are different in vegetable and graminea
hosts and is more immediate on fungi and algae than on bacteria (Ohshima et al., 1987). Furthermore, in the presence of more
than 0.025% chitosan, the growth of Excherichia coli, Fusarium, Alternaria and Helminthosporium is inhibited (Savard et al.,
2002). The inhibition of growth of these micro-organisms is due to cationic amino groups of chitosan which bind to anionic
groups. During the infectious period of a burn wound, bacterial infection may delay the healing and probably cause serious com-
plications, such as sepsis. Chitosan that is incorporated with minocycline hydrochloride was developed to achieve both wound
healing enhancement and antibacterial effects (Joshua et al., 2008).
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The substance or treatment that reduces inﬂammation is known as anti-inﬂammatory. Anti-inﬂammatory drugs make up
about half of analgesics that reduces inﬂammation thereby remedying pain in contrast to opioids, which affect the central nervous
system. Chitosan has a variety of promising biomedical applications and at this time, is considered as a new innovative material in
drug delivery systems, wound healing, antibacterial, fat binder, hemostatic agent, hypocholesterolemic effect as indicated by the
large number of studies published over the last few years (Shakeel and Saiqa, 2015a). Due to intraperitoneal administration of
acetic acid, chitosan treatment reduces inﬂammatory pain in a dose-dependent manner. Bradykinin is one of the main substances
related to pain. It was reported that the bradykinin concentration during administration of a chitosan-acid acetic solution in the
peritoneal lavage ﬂuid was lower than during the administration of a 0.5% acetic acid solution, suggesting that chitosan has an-
algesic effects. Chitosan that is formulated for wound management may induce analgesia by providing a cool, pleasant and sooth-
ing effect when applied to an open wound. Excellent pain relief was conferred by chitosan when it was applied as a topical agent
to open wounds, such as burns, skin abrasions, skin ulcers and skin grafted areas (Okamoto, 2002). Due to anti-inﬂammatory ef-
fects of chitosan, these are beneﬁcial for the treatment of prolonged inﬂammation at the wound site. Water-soluble chitosan sig-
niﬁcantly suppresses the secretion and expression of proinﬂammatory cytokines (e.g., tumour necrosis factor-α and interleukin-6)
and inducible nitric oxide synthase in astrocytes, the predominant neuroglial cells in the central nervous system, and is actively
involved in cytokine-mediated inﬂammatory events (Aoyagi et al., 2007). Moreover, N-acetylglucosamine is an anti-
inﬂammatory drug and is synthesized in the human body from glucose. It is incorporated into glycosaminoglycans and glycopro-
teins. Chito-oligosaccharides, which have a molecular weight of 5 kDa, showed better anti-inﬂammatory agents than nonsteroidal
anti-inﬂammatory drug, indomethacin (Kim et al., 2002). Chitosan exerts anti-inﬂammatory effects by inhibiting prostaglandin E2
and cyclooxygenase-2 protein expression and attenuating the pro-inﬂammatory cytokines (e.g., tumour necrosis factor-α and
interleukin-1β). However, chitosan treatment increases the expression of the anti-inﬂammatory cytokine, interleukin-10
(Spindola et al., 2009).
Biomedical Applications of Chitosan
In various disciplines of health care and hygienic applications, chitosan is used for contact disinfectants in many biomedical
applications, including wound dressing, drug delivery carrier orthopaedic tissue engineering, gene delivery, and haemodialysis.
Several biomedical applications of chitosan have already been reported (Fig. 3) (Zuo, 2014; Rinaudo, 2006). Chitosan has the
potential to be used as artiﬁcial kidney membrane, hypocholesterolemic agents, drug delivery systems, absorbable sutures and
supports for immobilized enzymes. Chitosan has some advantages due to its nontoxicity and biodegradability without damaging
the environment. It is a biocompatible material that breaks down slowly to harmless products that are absorbed completely in the
body (Neethu et al., 2015).
Wound Healings
Skin is the largest body organ, functioning as a barrier to harmful mediums, preventing pathogens from entering into the body.
A wound is result from physical, chemical, mechanical and/or thermal damages. The natural healing process of the skin isFig. 3. Various biomedical applications of chitosan.
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traditional autografts and allografts. As the tissue engineering is rising, it has emerged as an alternative treatment for excessive
skin loss. Wound dressing has attracted great interest in this area. Wound dressing materials have changed continuously and
signiﬁcantly during the past years. Nowadays many polymers, including natural materials, synthetic materials and combina-
tions of both types, nanoparticles immobilized polymer materials have been used for the application of skin regeneration
(Wen et al., 2015).Chitosan in Wound Healings
Wound healing is a particular biological route allied to the general phenomenon of growth and tissue regeneration. It
progresses through a series of inter-reliant and corresponding stages in which a variety of cellular and matrix components act to-
gether to regenerate the integrity of damaged tissue and replacement of lost tissue (Boateng et al., 2008). Wound healing is a
complex and dynamic regenerative process that is divided into four phases — haemostasis, inﬂammation, proliferation, and re-
modelling (Hani and Satya, 2013). The development of bacterial-resistant prosthetic counterparts through binding of an antibiotic
to the materials have been focussed. For example, chitosan hydrogel coated grafts, crosslinked upon ultraviolet light irradiation,
exhibited a resistance against E. coli in vitro and in vivo. The chitosan hydrogel directly acted as antibacterial biomaterial on a
Dacron graft, and was effective to inhibit the local infection (Fujita et al., 2004). A number of studies showed that chitosan
showed wound healing properties. The biocompatible carboxyethyl chitosan/poly(vinyl alcohol) (CECS/PVA) nanoﬁbres were
prepared by electrospinning of aqueous solution as wound dressing material. Cell culture results showed that ﬁbrous mats
were good in promoting the L929 cell attachment and proliferation (Zhou et al., 2008). The wound dressing should be non-
allergenic and non-toxic, keep moist environment, allows gas exchanges, protect the wound against microbial organisms and
absorb wound exudates (Croisier and Jérôme, 2013).
Haemorrhage remains a leading cause of early death after trauma, and infectious complications in combat wounds continue to
challenge caregivers. Although chitosan dressings have been developed to address these problems, they are not always effective in con-
trolling bleeding or killing bacteria. Immobilized onto poly(N-isopropylacrylamide) gel/polypropylene nonwoven composites surface
using the cross-linking agent (glutaraldehyde), chitosan hydrogels displayed antibacterial ability to E. coli and Staphylococcus aureus.
Meanwhile, the product showed easily stripped-off property without damaging the new regenerated tissue as it should be re-
moved from thewound (Chen et al., 2005a, 2005b). Composite sponge of curcumin/chitosan/gelatin was prepared at the various
ratios of chitosan and gelatin showing improved water uptake ability, antibacterial activity, and wound closure. The higher
content of gelatin in composite sponge exhibited a faster release behaviour up to 240 min. These composite sponges were
also found to enhance the formation of collagen and wound closure in vivo and therefore improved the wound healing activity
(Van et al., 2013).Chitosan with Synthetic/Natural Polymer Blend scaffolds in Wound Healings
Chitin grafted poly(acrylic acid) (PAA) was prepared with the aim of obtaining a hydrogel suitable for wound dressing
application. The morphology and behaviour of the cells on the chitin-PAA ﬁlm were found to be normal after 14 days of culture
(Tanodekaew et al., 2004). Ribeiro et al. (2009) developed chitosan hydrogel for wound dressing. In their study, ﬁbroblast cells
isolated from rat skin were used to assess the cytotoxicity of the hydrogel. The results showed that chitosan hydrogel was
able to promote cell adhesion and proliferation. Cell viability studies showed that the hydrogel and its degradation by-products
are non-cytotoxic. This study suggested that chitosan hydrogel may aid the reinstatement of skin architecture (Ribeiro et al.,
2009).
The biocompatible chitosan/polyethylene glycol diacrylate blend ﬁlms were successfully prepared by Michael addition reaction
with different weight ratios as wound dressing. Indirect cytotoxicity assessment of ﬁlms with mouse ﬁbroblasts (L929) indicated
that the material showed nocytotoxicity toward growth of L929 cell and had good in vitro biocompatibility and have the potential
to be used as wound dressing material (Zhang et al., 2008). Porous microspheres of chitosan and its derivatives were prepared in
order to deliver antigens in a controlled way (Mi et al., 1999). Mucoadhesivity of chitosan and its cationic derivatives is recog-
nized and proved to enhance the adsorption of drugs especially at neutral pH. N-trimethyl chitosan chloride interacts with the
negatively charged cell membranes thus, inhibit the growth of microorganisms (Hamman and Kotzé, 2002). Heterogeneous chem-
ical modiﬁcation of the chitosan ﬁlm can tune the surface properties of the ﬁlm; for instance, when a stearoyl group was attached
to the chitosan ﬁlms, they became more hydrophobic and promoted proteins adsorption. When chitosan ﬁlms were reacted with
succinic anhydride or phthalic anhydride, it resulted in more hydrophilic ﬁlms which promoted lysozyme adsorption
(Tangpasuthadol et al., 2003). The PVA/bentonite, PVA/Ag nanoparticles, PVA/clove extract, and PVA/cellulose nanocomposite
hydrogel was reported by Gonzalez et al. PVA/clove hydrogels did not exhibit a homogenous aspect, while PVA/bentonite and
PVA/Ag nanocomposite hydrogels showed signiﬁcant antimicrobial activity against growth of E. coli, good water vapour transmis-
sion rate, and adequate water absorbing capacity due to addition of clay and Ag nanoparticles as ﬁller (Gonzalez et al., 2011). For
effective wound healing accelerator, water-soluble chitosan/heparin complex was prepared by Kweon et al. using water-soluble
chitosan with wound healing ability and heparin with ability to attract or bind growth factor related to wound healing process
(Kweon et al., 2003).
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The biocompatible chitosan/sericin composite nanoﬁbres were fabricated by electrospinning having good morphology with di-
ameter between 240 nm and 380 nm. Furthermore, the composite nanoﬁbres showed good bactericidal activity against both of
Gram-positive and Gram-negative bacteria, could promote cell proliferation and are promising for wound dressing applications.
The cell viabilities for 24 h were over 90% at all test concentrations up to 250 g/mL, revealing the non-toxicities and good biocom-
patibilities of composite nanoﬁbres toward cells as shown in Fig. 4. Interestingly, we found that all of the cell viabilities were
greater than 100% compared to control group after 72 h incubation (Rui et al., 2014).
The selective sulfation at O-2 and/or O-3 of chitosan may generate potent antiretroviral agents that display a much higher
inhibitory effect on the infection of AIDS virus (Nishimura et al., 1998). The controlled silver sulfadiazine release was shown by
silver sulfadiazine incorporated CS membranes with controlled water vapour evaporation, adequate swelling ability,
cytocompatibility and prolonged antibacterial activity (Fwu et al., 2003). Silver sulfadiazine incorporated CS-alginate composite
membranes with excellent tensile strength and adequate elongation at break were developed in another report. The release
was enhanced when the alginate concentration was about 50%, thus suggesting release kinetics dependant on alginate (Meng
et al., 2010). Wang et al. evaluated the wound healing ability of PEC membrane of CS and alginate suspensions developed through
solvent casting method. The prepared membrane was nontoxic toward mouse and human ﬁbroblast cells. In vivo evaluation in
incisional wounds in rat proved the faster healing potential of this composite membrane (Wang et al., 2002). Silver sulfadiazine
incorporated bilayer wound dressing membrane composed of a soft upper layer and dense; a lower layer showing sustained re-
lease of silver sulfadiazine showed excellent antibacterial activity against Pseudomonas aeruginosa and S. aureus in the in vivo sys-
tem as well (Mi et al., 2002). Pang et al. developed a composite membrane which showed adequate mechanical strength,
excellent antibacterial activity against E. coli and tremendous haemostatic potential. This developed material was cytocompatible
toward human skin ﬁbroblast cells (Pang et al., 2008). Interestingly, a thermo-sensitive ﬁlm was prepared by combining thiolated
chitosan, poly(N-isopropyl acrylamide) and ciproﬂoxacin, so that by decreasing the temperature, the ﬁlm can easily be removed
from wound (Radhakumary et al., 2011).
A biocomposite coating containing chitosan, silver, and hydroxyapatite was developed on anodized titanium substrate by elec-
trochemical deposition and it exhibited antibacterial activity because of the synergistic effect of silver and chitosan. The needle-
like HAp crystal is observed in both HAp and CSAgHAp coatings; CSAgHAp crystal is denser and shorter from that of the high
magniﬁcation image (Fig. 5). The coatings show a uniform and porous surface, which is beneﬁcial to cell adhesion. These compos-
ite coatings could minimize the risk of infection and are promising materials with biomedical applications (Yajing et al., 2015).
The use of silver nanoparticles have exhibited improved antibacterial properties due to high surface area and high fraction of
surface atoms, leading to incorporating more nanoparticles inside the bacteria and promoting its efﬁcacy in a sustained manner
(Vimala et al., 2010). Silver nanoparticles exhibit signiﬁcantly novel and distinct physical, chemical, and biological properties
and functionality due to their nanoscale size, have elicited much interest, over the past few decades. Due to antimicrobial nature
of silver nanoparticles, it has potential to heal the wounds (Shakeel and Saiqa, 2015b, 2015c; Shakeel et al., 2016a, 2016b). The
antibacterial potential of nanosilver incorporated and chitosan hydrogel composite bandage the developed scaffolds showing
high swelling ratio, controlled biodegradation and excellent blood clotting ability. The composite bandages showed excellent an-
tibacterial potential against S. aureus and E. coli and found to be suitable for wound healing applications. Biocompatibility of the
prepared scaffolds toward Vero cells, proved the non-toxic nature of the composite bandages (Madhumathi et al., 2010; Chen
et al., 2011).Fig. 4. The cell viability of L929 ﬁbroblasts in different concentrations of nanoﬁbres culture medium for 24, 48, and 72 h (Rui et al., 2014) (Reproduced with per-
mission from Elsevier).
Fig. 5. FESEM surface morphology images of the prepared coatings on TNs: (a and b) HAp, (c and d) CSAgHAp (Yajing et al., 2015) (Reproduced with permission
from Elsevier).
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lowered the water uptake, reduced the pore size of the porous structure, decreased the in vitro degradation, but increased the
compressive modulus of the chitosan/PGA PECs. Furthermore, the chitosan/PGA PECs provided adequate moisture, and thus, re-
duced the risk of dehydration in the presence of PGA. The wounds treated with the chitosan/PGA PECs healed signiﬁcantly faster
than wounds given no treatment (Ching et al., 2011).
The chitosan (CS)/gelatin (GE) composite nanoﬁber membranes were electrospun. The excellent mechanical enhancement can
be explained by the effective dispersion of ﬁllers and the ﬁller-matrix interactions, which ensures the efﬁcient load transfer from
CS/GE matrix to Fe3O4 nanoﬁllers. Moreover, zones of inhibition for E. coli and S. aureus expanded markedly with the supplement
of Fe3O4 NPs. In all, nanoﬁber membranes made of Fe3O4/CS/GE composite with tailored mechanical and antibacterial properties
appear a promising wound dressing material (Ning et al., 2016). The poly(vinyl alcohol)/chitosan/montmorillonite nanocomposite
hydrogels were prepared by freezing–thawing method, as a biocompatible wound dressing. Improved mechanical properties of
this system along with the other characteristics such as biocompatibility, antibacterial activity and good swelling behaviour,
made it desirable candidate for wound dressing applications (Nooria et al., 2015).
Chitosan Based Sponges in Wound Healing
Sponges are nothing else than foams with an open porosity. These solid structures are able to absorb high amount of ﬂuids
(more than 20 times their dry weight), due to their micro-porosity. They typically offer good cell interaction, still being soft
and ﬂexible. Chitosan sponges are mainly used as wound healing materials, as they can soak up the wound exudates, while help-
ing the tissue regeneration. Chitosan sponges also ﬁnd application in bone tissue engineering, as a ﬁlling material (Jayakumar
et al., 2011). Mei Dai et al. reported a biodegradable sponge which is composed of chitosan and sodium alginate loaded with
curcumin. Histological results of three different kinds of wound dressings applied on the dorsal skin wound of SD rat. The
gauze-treated wounds showed immature granulation tissue with congested vessels and numerous inﬂammatory cells. The dermis
is still under the process of remodelling on 12th day of dressing. However, in the C2A2 sponge and C2A2-curcumin sponge-
treated wounds, the granulation tissue and collagen alignment were more advanced in comparison to the gauze-treated wounds.
These two kinds of sponges-treated wounds demonstrated compact and well-aligned collagen, showing that the wounds were
under a better healing environment. In wound healing testing, full-thickness wounds were made on the back of each rat using
C2A2 sponge as wound dressing (Mei et al., 2009).
The sponge-like dressings based on chitosan glutamate (high molecular weight) and sericin was developed for the treatment
of chronic skin ulcers. The amount of sericin in the optimized dressing is suitable to exert a protective effect on human ﬁbroblasts
against oxidative damage. Moreover, the optimized dressing is able to improve ﬁbroblast proliferation, that is, to promote wound
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plication. In 2009, efforts were dedicated to the use of supercritical carbon dioxide (scCO2) as a green medium to induce porosity
to chitosan scaffolds (Kumari et al., 2009). Cross-linked chitosan sponges loaded with a model of antibiotic drug — the norﬂoxacin
were prepared by solvent evaporation technique (Emiir et al., 2004). Absorbable and non-absorbable dressings have been fabri-
cated into sponges via a modiﬁed thermally induced phase separation method, using a grafted derivative of chitosan with 2-
hydroxyethylacrylate. The In vitro release studies in simulated body ﬂuids give a burst effect due to the surface entrapment of
the drug and its amorphization in the ﬁrst 3 h as well as a low release rate until complete dissolution time that reaches 24 h.
Results encouraged that loaded sponge with Levo even at low concentrations, offers a promising solution in wound infections
management, providing increased tolerability, safety and antibacterial protection against common susceptible and resistant
wound pathogens (Panoraia et al., 2016).Chitosan Based Oil Immobilized Scaffolds in Wound Healings
The castor oil-based ﬁlms reinforced with different amounts of CS-modiﬁed ZnO nanoparticles were successfully prepared via
solution mixing and casting technique. The nanocomposites exhibited antimicrobial activity against both Gram-negative and
Gram-positive bacteria in the presence and the absence of UV light, and the effect increased with the CS-ZnO concentration.
From the morphology, water absorption, thermal stability, biodegradability, cytocompatibility, barrier, mechanical, viscoelastic,
wound healing, and antibacterial studies of the these bionanocomposites, these are found to be promising for use in biomedical
applications, particularly as wound healing materials (Ana and Angel, 2015).Chitosan Based Extract Immobilized Scaffolds in Wound Healings
Hydrogel ﬁlms are very soft and cause no disturbance during its applications in wound dressings. Plant extract is natural an-
timicrobials exhibiting low compatibility in the hydrogel polymeric solution and their release and effectiveness in hydrogel ﬁlms
are low as compared to its pure form. Plants are more potent healers and heal the wounds in a naturel way. Hydrogel ﬁlm en-
capsulated with gentamycin sulphate, Salix alba and Juglena regia leaves extract showed both antibacterial and antifungal activities
in disc diffusion method and in MIC. Since these properties are the most important properties for ideal wound healing materials
which provides a future site to treat wound care system (Mohammad and Fehmeeda, 2014, 2015a, 2015b; Mohammad et al.,
2015).
Wounds are frequently contaminated with a variety of bacteria, so the potential for infection is always present. This has en-
couraged the development of improved wound dressings that show an antimicrobial effect through the incorporation or not of
antimicrobial agents. The use of the therapeutic properties of aloe-vera could be very useful in the creation of active wound dress-
ing materials. The chitosan/aloe-vera based membranes were developed as wound dressing materials. The addition of aloe vera to
chitosan enhanced the antimicrobial potential of the resulting membranes. CAV1 (CS:AV:1:1, v/w) showed the highest antibacte-
rial potential compared with the other formulations (Fig. 6) indicating the greater effectiveness of CAV1 as a bactericide which
could be due to greater content of AV in the membrane, which consequently increases its inhibitory potency. On the chitosan
membrane (Fig. 7), hDFs exhibited a round morphology with cell agglomeration throughout the study period. Cells seeded on
the CAV membrane showed better spreading and a higher number of cells attached to the surface. From days 1 to 7 the cells
were uniformly distributed on the surface of the CAV membrane, exhibiting a spindle-like shape typical of ﬁbroblasts, suggesting
good adherence to this surface. Moreover, on day 7 hDFs were well spread on and were able to adhere to both sides of the CAV
membrane surface. Despite the good cell adhesion and proliferation observed on the CAV membrane, the higher AV content of
CAV1 did not result in the expected increase in cell spreading and proliferation. The chitosan/aloe vera based membranes
might be promising wound dressing materials (Silva et al., 2013).Fig. 6. Photographic image of the developed membranes (Cht, CAV and CAV1) on culture plates inoculated with S. aureus after 72 h (Silva et al., 2013) (Reproduced
with permission from Elsevier).
Fig. 7. Calcein-AM staining of hDFb cells cultured for 1, 3 and 7 days on the membranes (Cht, CAV and CAV1) (Silva et al., 2013) (Reproduced with permission
from Elsevier).
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Researcher have also tried to use drug loaded chitosan based scaffolds. The thiolated chitosan with poly(N-isopropyl acrylam-
ide) loaded with ciproﬂoxacin was cytocompatible and found to modulate the release of the incorporated ciproﬂoxacin in a
sustained fashion reﬂecting its suitability to protect a wound for a prolonged period. The combination of thiolated chitosan
with poly(N-isopropyl acrylamide) and ciproﬂoxacin showed antibacterial properties to the virulent bacteria E. coli supporting
its potential as a wound dressing (Radhakumary et al., 2011).
Conclusions and Future Prospective
In this review, the various properties such as antimicrobial, anti-inﬂammatory and biomedical applications of chitosan based
materials especially wound dressings have been covered. Chitosan has been shown to be a potential biomaterial to be used in
wound healing due to its antimicrobial and anti-inﬂammatory nature. Effective dressings should have characteristics optimized
for particular type of wound at a reasonable low cost and with minimum inconvenience to patients. Many results have been
reported, but complete and standard characterization of these materials is needed. Therefore, there is need to manipulate the
physical properties of identiﬁed systems to achieve such objectives.
Although a lot of literature is available on chitosan and modiﬁed chitosan (blends/composites/derivatives) for wound healing,
there are many challenges which need to be explored in process of wound healing. We expect that this article will provide
insights on the use of these important chitosan based materials for researchers working in the ﬁeld of biomedical and
pharmaceutical sciences.
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